Connexins: A connection with the skin

Experimental Dermatology

Volumn 9, Issue 2, 2000, Pages 77-96

  Richard, Gabriela ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Connexin; D ifferentiation; Erythrokeratodermia variabilis; Gap junctional intercellular communication; Hearing loss; Mutation; Palmoplantar keratoderma; Vohwinkel syndrome

Indexed keywords

GAP JUNCTION PROTEIN;

CELL COMMUNICATION; CONGENITAL DEAFNESS; CONGENITAL SKIN DISEASE; EPIDERMIS; GAP JUNCTION; GENE MUTATION; GROWTH; HUMAN; KERATOSIS PALMOPLANTARIS; MORPHOGENESIS; NONHUMAN; ORGAN DISTRIBUTION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SKIN; TISSUE DIFFERENTIATION;

CELL COMMUNICATION; CONNEXINS; EAR, INNER; GAP JUNCTIONS; HUMANS; MUTATION; SKIN DISEASES; SKIN PHYSIOLOGY;

EID: 0034068362     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2000.009002077.x     Document Type: Review

References (127)

1. Bergoffen J, Scherer S S, Wang S et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993: 262: 2039-2042.
2. Bruzzone R, White T W, Scherer S S, Fischbeck K H, Paul D L. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 1994: 13: 1253-1260.
3. Fairweather N, Bell C, Cochrane S et al. Mutations in the connexin 32 gene in X-linked Charcot-Marie-Tooth disease. Hum Mol Genet 1994: 3: 29-34.
4. Britz-Cunningham S H, Shah M M, Zuppan C W, Fletcher W H. Mutations of the Connexin 43 gap-junction gene in patients with heart malformations and defects of laterality [see comments]. N Engl J Med 1995: 332: 1323-1329.
5. Berry V, Mackay D, Khaliq S et al. Connexin 50 mutation in a family with congenital "zonular nuclear" pulverulent cataract of Pakistani origin. Hum Genet 1999: 105: 168-170.
6. Mackay D, Ionides A, Kibar Z et al. Connexin 46 mutations in autosomal dominant congenital cataract. Am J Hum Genet 1999: 64: 1357-1364.
7. Shiels A, Mackay D, Ionides A, Berry V, Moore A. A missense mutation in the human connexin-50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet 1998: 62: 526-532.
8. Kelsell D P, Dunlop J, Stevens H P et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997: 387: 80-83.
9. Zelante L, Gasparini P, Estivill X et al. Connexin 26 mutations associated with the most common form of nonsyndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997: 6: 1605-1609.
10. Denoyelle F, Weil D, Maw M A et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997: 6: 2173-2177.
11. Lench N J, Mueller R F, Houseman M et al. Autosomal recessive non-syndromic deafness (DFNA3/DFNB1): connexin 26 mutation analysis in Middle Eastern and Caucasian populations. Am J Hum Genet 1997: 61: A22.
12. Estivill X, Fortina P, Surrey S et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 1998: 351: 394-398.
13. Lench N, Houseman M, Newton V, Van Camp G, Mueller R. Connexin-26 mutations in sporadic non-syndromal sensorineural deafness. Lancet 1998: 351: 415.
14. Kelley P M, Harris D J, Comer B C et al. Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet 1998: 62: 792-799.
15. Green G E, Scott D A, McDonald J M et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. Jama 1999: 281: 2211-2216.
16. Carrasquillo M M, Zlotogora J, Barges S, Chakravarti A. Two different connexin 26 mutations in an inbred kindred segregation non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet 1997: 6: 2163-2172.
17. White T W, Deans M R, Kelsell D P, Paul D L. Connexin mutations in deafness [letter; comment]. Nature 1998: 394: 630-631.
18. Richard G, White T W, Smith L E et al. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet 1998: 103: 393-399.
19. Martin P E, S L C, Casalotti S O, Forge A, Evans W H. Properties of connexin 26 gap junctional proteins derived from mutations associated with non-syndromal hereditary deafness [In Process Citation]. Hum Mol Genet 1999: 8: 2369-2376.
20. Denoyelle F, Lina-Granade G, Plauchu H et al. Connexin 26 gene linked to a dominant deafness [letter]. Nature 1998: 393: 319-320.
21. Grifa A, Wagner C A, D'Ambrosio L et al. Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus [letter]. Nat Genet 1999: 23: 16-18.
22. Xia J H, Liu C Y, Tang B S et al. Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet 1998: 20: 370-373.
23. Richard G, Smith L E, Bailey R A et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998: 20: 366-369.
24. Richard G, Brown K, Smith L et al. The spectrum of mutations in erythrokeratodermias-Novel and de novo mutations in GJB3. Hum Genet, in press 1999.
25. Wilgoss A, Leigh I M, Barnes M R et al. Identification of a novel mutation R42P in the gap junction protein beta-3 associated with autosomal dominant erythrokeratoderma variabilis. J Invest Dermatol 1999: 113: 1119-1122.
26. Maestrini E, Korge B P, Ocana-Sierra J et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999: 8: 1237-1243.
27. Yeager M, Nicholson B J. Structure of gap junction intercellular channels. Curr Opin Struct Biol 1996: 6: 183-192.
28. Beardslee M A, Laing J G, Beyer E C, Saffitz J E. Rapid turnover of connexin43 in the adult rat heart [see comments]. Circ Res 1998: 83: 629-635.
29. Brink P R. Gap junctions in vascular smooth muscle. Acta Physiol Scand 1998: 164: 349-356.
30. Laird D W. The life cycle of a connexin: gap junction formation, removal, and degradation. J Bioenerg Biomembr 1996: 28: 311-318.
31. Jordan K, Solan J L, Dominguez M et al. Trafficking, assembly, and function of a connexin43-green fluorescent protein chimera in live mammalian cells. Mol Biol Cell 1999: 10: 2033-2050.
32. Bruzzone R, White T W, Paul D L. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996: 238: 1-27.
33. Kim D Y, Kam Y, Koo S K, Joe C O. Gating connexin 43 channels reconstituted in lipid vesicles by mitogen-activated protein kinase phosphorylation. J Biol Chem 1999: 274: 5581-5587.
34. Yeager M. Structure of cardiac gap junction intercellular channels [In Process Citation]. J Struct Biol 1998: 121: 231-245.
35. Unger V M, Kumar N M, Gilula N B, Yeager M. Three-dimensional structure of a recombinant gap junction membrane channel. Science 1999: 283: 1176-1180.
36. White T W, Paul D L, Goodenough D A, Bruzzone R. Functional analysis of selective interactions among rodent connexins. Mol Biol Cell 1995: 6: 459-470.
37. Rubin J B, Verselis V K, Bennett M V, Bargiello T A. Molecular analysis of voltage dependence of heterotypic gap junctions formed by connexins 26 and 32. Biophys J 1992: 62: 183-193; discussion 193-195.
38. Suchyna T M, Xu L X, Gao F, Fourtner C R, Nicholson B J. Identification of a proline residue as a transduction element involved in voltage gating of gap junctions. Nature 1993: 365: 847-849.
39. Jiang J X, Goodenough D A. Heteromeric connexons in lens gap junction channels. Proc Natl Acad Sci U S A 1996: 93: 1287-1291.
40. Stauffer K A. The gap junction proteins beta 1-connexin (connexin-32) and beta 2-connexin (connexin-26) can form heteromeric hemichannels. J Biol Chem 1995: 270: 6768-6772.
41. Dahl G, Werner R, Levine E, Rabadan-Diehl C. Mutational analysis of gap junction formation. Biophys J 1992: 62: 172-180; discussion 180-182.
42. Elfgang C, Eckert R, Lichtenberg-Frate H et al Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 1995: 129: 805-817.
43. Choudhry R, Pitts J D, Hodgins M B. Changing patterns of gap junctional intercellular communication and connexin distribution in mouse epidermis and hair follicles during embryonic development. Dev Dyn 1997: 210: 417 430.
44. Kam E, Melville L, Pitts J D. Patterns of junctional communication in skin. J Invest Dermatol 1986: 87: 748-753.
45. Lo C W The role of gap junction membrane channels in development. J Bioenerg Biomembr 1996: 28: 379-385.
46. Matic M, Petrov I N, Rosenfeld T, Wolosin J M. Alterations in connexin expression and cell communication in healing corneal epithelium. Invest Ophthalmol Vis Sci 1997: 38: 600-609.
47. Dahl E, Winterhager E, Reuss B et al. Expression of the gap junction proteins connexin31 and connexin43 correlates with communication compartments in extraembryonic tissues and in the gastrulating mouse embryo, respectively. J Cell Sci 1996: 109: 191-197.
48. Veenstra R D. Size and selectivity of gap junction channels formed from different connexins. J Bioenerg Biomembr 1996: 28: 326-337.
49. Brissette J L, Kumar N M, Gilula N B, Hall J E, Dotto G P. Switch in gap junction protein expression is associated with selective changes in junctional permeability during keratinocyte differentiation. Proc Natl Acad Sci U S A 1994: 91: 6453-6457.
50. Thomas A P, Renard-Rooney D C, Hajnoczky G et al. Subcellular organization of calcium signalling in hepatocytes and the intact liver. Ciba Found Symp 1995: 188: 18-35.
51. Blomstrand F, Aberg N D, Eriksson P S, Hansson E, Ronnback L. Extent of intercellular calcium wave propagation is related to gap junction permeability and level of connexin-43 expression in astrocytes in primary cultures from four brain regions. Neuroscience 1999: 92: 255-265.
52. Bevans C G, Kordel M, Rhee S K, Harris A L. Isoform composition of connexin channels determines selectivity among second messengers and uncharged molecules. J Biol Chem 1998: 273: 2808-2816.
53. Bevans C G, Harris A E. Direct high affinity modulation of connexin channel activity by cyclic nucleotides [In Process Citation]. J Biol Chem 1999: 274: 3720-3725.
54. Echetebu C O, Ali M, Izban M G, MacKay E, Garfield R E. Eocalization of regulatory protein binding sites in the proximal region of human myometrial connexin 43 gene. Mol Hum Reprod 1999: 5: 757-766.
55. Neuhaus I M, Dahl G, Werner R. Use of alternate promoters for tissue-specific expression of the gene coding for connexin32. Gene 1995: 158: 257-262.
56. Sohl G, Gillen C, Bosse F et al. A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol 1996: 69: 267-275.
57. Piechocki M P, Burk R D, Ruch R J. Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells. Carcinogenesis 1999: 20: 401-106.
58. Butterweck A, Elfgang K, Willeke K, Traub O. Differential expression of the gap junction proteins connexin-45. -43, -40, -31, and -26 in mouse skin. Eur J Cell Biol 1994: 65: 152-163.
59. Haefliger J A, Bruzzone R, Jenkins N A et al. Four novel members of the connexin family of gap junction proteins. Molecular cloning, expression, and chromosome mapping. J Biol Chem 1992: 267: 2057-2064.
60. Hennemann H, Dahl E, White J B et al. Two gap junction genes, connexin 31.1 and 30.3, are closely linked on mouse chromosome 4 and preferentially expressed in skin. J Biol Chem 1992: 267: 17225-17233.
61. Risek B, Klier F G, Gilula N B. Multiple gap junction are utilized during rat skin and hair development. Development 1992: 116: 639-651.
62. Abdulla S. Getting to the heart of gap junction pathology. Novartis Foundations Symposium: Gap junction-mediated intercellular signalling in health and disease. London, UK, 3-5 March 1998. Mol Med Today 1998: 4: 192-193.
63. Beyer E C, Reed K E, Westphale E M, Kanter H E, Larson D M. Molecular cloning and expression of rat connexin40, a gap junction protein expressed in vascular smooth muscle. J Membr Biol 1992: 127: 69-76.
64. Guo H, Acevedo P, Parsa F D, Bertram J S. Gap-junctional protein connexin 43 is expressed in dermis and epidermis of human skin: differential modulation by retinoids. J Invest Dermatol 1992: 99: 460-467.
65. Earson D M, Wrobleski M J, Sagar G D, Westphale E M, Beyer E C. Differential regulation of connexin43 and connexin37 in endothelial cells by cell density, growth, and TGF-betal. Am J Physiol 1997: 272: C405-415.
66. Reed K E, Westphale E M, Larson D M et al. Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein. J Clin Invest 1993: 91: 997-1004.
67. Traub O, Hertlein B, Kasper M et al. Characterization of the gap junction protein connexin37 in murine endothelium, respiratory epithelium, and after transfection in human HeLa cells. Eur J Cell Biol 1998: 77: 313-322.
68. Manthey D, Bukauskas F, Lee C G, Kozak C A, Willecke K. Molecular cloning and functional expression of the mouse gap junction gene connexin-57 in human HeLa cells. J Biol Chem 1999: 274: 14716-14723.
69. Goliger J A, Paul D L. Expression of gap junction proteins cx26, cx31.1, cx37, and cx43 in developing and mature rat epidermis. Devel Dyn 1994: 200: 1-13.
70. Kamibayashi Y, Oyamada M, Oyamada Y, Mori M. Expression of gap junction proteins connexin 26 and 43 is modulated during differentiation of keratinocytes in newborn mouse epidermis. J Invest Dermatol 1993: 101: 773-778.
71. Kamibayashi Y, Oyamada Y, Mori M, Oyamada M. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 1995: 16: 1287-1297.
72. Salomon D. Saurat J H, Meda P. Cell-to-cell communication within intact human skin. J Clin Invest 1988: 82: 248-254.
73. Lucke T, Choudhry R, Thorn R et al. Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 1999: 112: 354-361.
74. Salomon D, Masgrau E, Vischer S et al. Topography of mammalian connexins in human skin. J Invest Dermatol 1994: 103: 240-247.
75. Tada J, Hashimoto K. Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma. J Cutan Pathol 1997: 24: 628-635.
76. Richard G, Andreoli J M, Compton J G. Expression of epidermal connexins in erythrokeratodermia variabilis (EKV) and normal skin. J Invest Dermatol 1997: 108: 587.
77. Goliger J A, Paul D L. Wounding alters epidermal connexin expression and gap junction-mediated intercellular communication. Mol Biol Cell 1995: 6: 1491-1501.
78. Labarthe M R Bosco D, Saurat J H, Meda P, Salomon D. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol 1998: 111: 72-76.
79. Rivas M V, Jarvis E D, Morisaki S et al. Identification of aberrantly regulated genes in diseased skin using the cDNA differential display technique. J Invest Dermatol 1997: 108: 188-194.
80. Sawey M J, Goldschmidt M H, Risek B, Gilula N B, Lo C W. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia. Mol Carcinog 1996: 17: 49-61.
81. Masgrau-Peya E, Salomon D, Saurat J H, Meda P. In vivo modulation of connexins 43 and 26 of human epidermis by topical retinoic acid treatment. J Histochem Cytochem 1997: 45: 1207-1215.
82. Risek B, Pozzi A, Gilula N B. Modulation of gap junction expression during transient hyperplasia of rat epidermis. J Cell Sci 1998: 111: 1395-1404.
83. Budunova I V, Carbajal S, Slaga T J. The expression of gap junctional proteins during different stages of mouse skin carcinogenesis. Carcinogenesis 1995: 16: 2717-2724.
84. Noguchi M, Nomata K, Watanabe J I et al. Disruption of gap junctional intercellular communication in human renal cancer cell lines. Urology 1999: 53: 218-222.
85. Budunova I V, Carbajal S, Viaje A, Slaga T J. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors. Mol Carcinog 1996: 15: 190-201.
86. Yamasaki H, Omori Y, Zaidan-Dagli M L et al. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis. Cancer Detect Prev 1999: 23: 273-279.
87. Mesnil M, Krutovskikh V, Piccoli C et al. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res 1995: 55: 629-639.
88. Lee S W, Tomasetto C, Paul D, Keyomarsi K, Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 1992: 118: 1213-1221.
89. Omori Y, Duflot-Dancer A, Mesnil M, Yamasaki H. Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects. Toxicol Lett 1998: 96-97: 105-110.
90. Omori Y, Yamasaki H. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wildtype connexin43 in a dominant-negative manner. Int J Cancer 1998: 78: 446-453.
91. Duflot-Dancer A, Mesnil M, Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 1997: 15: 2151-2158.
92. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci U S A 1996: 93: 1831-1835.
93. Colombo B M, Benedetti S, Ottolenghi S et al. The "by-stander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 1995: 6: 763-772.
94. Mesnil M, Piccoli C, Yamasaki H. A tumor suppressor gene, Cx26, also mediates the bystander effect in HeLa cells. Cancer Res 1997: 57: 2929-2932.
95. Richard G, Itin P, Bale S J, DiGiovanna J J. Clinical heterogeneity in EKV J Invest Dermatol 1998: 110: 616A.
96. Richard G, Lin J P, Smith L et al. Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes. J Invest Dermatol 1997: 109: 666-671.
97. Itin P H, Pittelkow M R. Erythrokeratodermia figurata variabilis: immunocytochemistry and ultrastructure. Dermatologica 1990: 181: 175A.
98. Brown J, Kierland R R. Erythrokeratodermia variabilis. Report of three cases and review of the literature. Arch Dermatol 1966: 93: 194-201.
99. Vandersteen P R, Muller S A. Erythrokeratodermia variabilis. An enzyme histochemical and ultrastructural study. Arch Dermatol 1971: 103: 362-370.
100. Rappaport I P, Goldes J A, Goltz R W. Erythrokeratodermia variabilis treated with isotretinoin. A clinical, histologic, and ultrastructural study. Arch Dermatol 1986: 122: 441-445.
101. van der Schroeff J G, Ruiter D J, Bots G T. Epidermal Langerhans cells in erythrokeratodermia variabilis. Histochemical and ultrastructural investigations before and after treatment with etretinate (RO 10-9359). Arch Dermatol Res 1982: 274: 339-348.
102. MacFarlane A W, Chapman S J, Verbov J L. Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings. Br J Dermatol 1991: 124: 487-491.
103. Ishida-Yamamoto A, McGrath J A, Lam H et al. The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 1997: 61: 581-585.
104. Korge B P, Ishida-Yamamoto A, Punter C et al Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997: 109: 604-609.
105. Maestrini E, Monaco A P, McGrath J A et al. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996: 13: 70-77.
106. van der Schroeff J G, Nijenhuis L E, Meera Khan P et al. Genetic linkage between erythrokeratodermia variabilis and Rh locus. Hum Genet 1984: 68: 165-168.
107. van der Schroeff J G, van Leeuwen-Cornelisse I, van Haeringen A, Went L N. Further evidence for localization of the gene of erythrokeratodermia variabilis. Hum Genet 1988: 80: 97-98.
108. Boerma M, Forsberg L, Van Zeijl L et al. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999: 246:211-218.
109. Schwarz H J, Chang Y S, Hennemann H et al. Chromosomal assignments of mouse connexin genes, coding for gap junctional proteins, by somatic cell hybridization. Somat Cell Mol Genet 1992: 18: 351-359.
110. Wenzel K, Manthey D, Willecke K, Grzeschik K H, Traub O. Human gap junction protein connexin31: molecular cloning and expression analysis. Biochem Biophys Res Commun 1998: 248: 910-915.
111. Tucker M A, Barajas L. Rat connexins 30.3 and 31 are expressed in the kidney. Exp Cell Res 1994: 213: 224-230.
112. Hoh J H, John S A, Revel J P. Molecular cloning and characterization of a new member of the gap junction gene family, connexin-31. J Biol Chem 1991: 266: 6524-6531.
113. Deschenes S M, Walcott J L, Wexler T L, Scherer S S, Fischbeck K H. Altered trafficking of mutant connexin32. J Neurosci 1997: 17: 9077-9084.
114. Verselis V K, Ginter C S, Bargiello T A. Opposite voltage gating polarities of two closely related connexins. Nature 1994: 368: 348-351.
115. Goodenough D A, Goliger J A, Paul D L. Connexins, Connexons, and intercellular communication. Annu Rev Biochem 1996: 65: 475-502.
116. Rouger H, LeGuern E, Birouk N et al. Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: characterization of 14 Cx32 mutations in 35 families. Hum Mutat 1997: 10: 443-452.
117. Crosby E F, Vidurrizaga R H. Knuckle pads, leuconychia, deafness, and keratosis palmoplantaris. Johns Hopkins Med J 1976: 139: S90-S92.
118. Fitzgerald D A, Verbov J L. Hereditary palmoplantar keratoderma with deafness. J Dermatol 1996: 134: 939-942.
119. Gloor M, Gross M, Happle R, Gehring W. Familäre zirkumskripte Palmoplantarkeratose mil Schallempfindungsschwerhörigkeit und sporadischem CHILD Syndrom Hautarzt 1989: 40: 304-307.
120. Hatamochi A, Nakagawa S H U. Diffuse palmoplantar keratoderma with deafness. Arch Dermatol 1982: 118: 605-607.
121. Sharland M, Bleach N R, Goberdhan P D, Patton M A. Autosomal dominant palmoplantar hyperkeratosis and sensorineural deafness in three generations. J Med Genet 1992: 29: 50-52.
122. Verbov J L. Palmoplantar keratoderma, deafness and atopy. Br J Dermatol 1987: 116: 881-882.
123. Vohwinkel K H. Keratoma hereditarium mutilans. Arch Derm Syph 1929: 158: 354-364.
124. Scott D A, Kraft M L, Stone E M, Sheffield V C, Smith R J. Connexin mutations and hearing loss [letter]. Nature 1998: 391: 32.
125. Kelsell D, Wilgoss A, Leigh I. Connexin mutations in skin disease and deafness: Genotype versus phenotype. J Invest Dermatol 1999: 113: 433.
126. Rouan F, White T, Paul D, Uitto J, Richard G. Transdominant negative effect of a novel connexin-26 mutation on connexin-43 channels as possible mechanism for cutaneous phenotype. Mol Biol Cell 1999: 10: 402a.
127. Hodgins M, Munro C, Shore L et al. The skin phenotypes of dominant Connexin 26 mutations. J Invest Dermatol 1999: 113: 444.